Literature DB >> 25104866

Chemotherapy-free conditioning: one step closer.

Andrew R Gennery1, Mary A Slatter1.   

Abstract

Mesh：

Year:  2014        PMID： 25104866      PMCID： PMC4126325          DOI： 10.1182/blood-2014-06-579680

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening.

Authors:  Lucinda Brown; Jinhua Xu-Bayford; Zoe Allwood; Mary Slatter; Andrew Cant; E Graham Davies; Paul Veys; Andrew R Gennery; H Bobby Gaspar
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

2.  Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype.

Authors:  Marina Cavazzana-Calvo; Frédérique Carlier; Françoise Le Deist; Estelle Morillon; Pierre Taupin; David Gautier; Isabelle Radford-Weiss; Sophie Caillat-Zucman; Bénédicte Neven; Stephane Blanche; Rémi Cheynier; Alain Fischer; Salima Hacein-Bey-Abina
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

3.  Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

Authors:  Andrew R Gennery; Mary A Slatter; Laure Grandin; Pierre Taupin; Andrew J Cant; Paul Veys; Persis J Amrolia; H Bobby Gaspar; E Graham Davies; Wilhelm Friedrich; Manfred Hoenig; Luigi D Notarangelo; Evelina Mazzolari; Fulvio Porta; Robbert G M Bredius; Arjen C Lankester; Nico M Wulffraat; Reinhard Seger; Tayfun Güngör; Anders Fasth; Petr Sedlacek; Benedicte Neven; Stephane Blanche; Alain Fischer; Marina Cavazzana-Calvo; Paul Landais
Journal:  J Allergy Clin Immunol       Date:  2010-07-31       Impact factor: 10.793

Review 4.  Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.

Authors:  Jaap J Boelens; Vinod K Prasad; Jakub Tolar; Robert F Wynn; Charles Peters
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

5.  Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.

Authors:  Jaap Jan Boelens; Mieke Aldenhoven; Duncan Purtill; Annalisa Ruggeri; Todd Defor; Robert Wynn; Ed Wraith; Marina Cavazzana-Calvo; Attilio Rovelli; Alain Fischer; Jakub Tolar; Vinod K Prasad; Maria Escolar; Eliane Gluckman; Anne O'Meara; Paul J Orchard; Paul Veys; Mary Eapen; Joanne Kurtzberg; Vanderson Rocha
Journal:  Blood       Date:  2013-03-14       Impact factor: 22.113

6.  In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice.

Authors:  S Christopher Derderian; P Priya Togarrati; Charmin King; Patriss W Moradi; Damien Reynaud; Agnieszka Czechowicz; Irving L Weissman; Tippi C MacKenzie
Journal:  Blood       Date:  2014-05-30       Impact factor: 22.113

7.  Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.

Authors:  Antonia Kwan; Joseph A Church; Morton J Cowan; Rajni Agarwal; Neena Kapoor; Donald B Kohn; David B Lewis; Sean A McGhee; Theodore B Moore; E Richard Stiehm; Matthew Porteus; Constantino P Aznar; Robert Currier; Fred Lorey; Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2013-07       Impact factor: 10.793

8.  SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

Authors:  Catharina Schuetz; Benedicte Neven; Christopher C Dvorak; Sandrine Leroy; Markus J Ege; Ulrich Pannicke; Klaus Schwarz; Ansgar S Schulz; Manfred Hoenig; Monika Sparber-Sauer; Susanne A Gatz; Christian Denzer; Stephane Blanche; Despina Moshous; Capucine Picard; Biljana N Horn; Jean-Pierre de Villartay; Marina Cavazzana; Klaus-Michael Debatin; Wilhelm Friedrich; Alain Fischer; Morton J Cowan
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

Review 9.  B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?

Authors:  Elie Haddad; Sandrine Leroy; Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2013-03-05       Impact factor: 10.793

10.  Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.

Authors:  Amel Hassan; Pamela Lee; Paraskevi Maggina; Jin Hua Xu; Diana Moreira; Mary Slatter; Zohreh Nademi; Austen Worth; Stuart Adams; Alison Jones; Catherine Cale; Zoe Allwood; Kanchan Rao; Robert Chiesa; Persis Amrolia; Hubert Gaspar; E Graham Davies; Paul Veys; Andrew Gennery; Waseem Qasim
Journal:  J Allergy Clin Immunol       Date:  2014-05-01       Impact factor: 10.793
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.